China’s pharma innovators pursue a range of deal structures to support global expansion
[co-author: Paul Jing]* Thanks to its scientific skills base, growing prowess in AI and a policy environment that supports rapid clinical trials, China has become one of the world’s leading markets for pharmaceutical innovation. Here we explore how the …